Dysmenorrhea treatment SEO Brief & AI Prompts

Dysmenorrhea and menstrual pain is defined as recurrent, crampy lower abdominal pain during menstruation and is treated first-line with nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal contraception per ACOG and NICE; primary dysmenorrhea usually begins within 6–12 months of menarche while secondary dysmenorrhea reflects an identifiable pelvic pathology such as endometriosis, adenomyosis, fibroids, or pelvic inflammatory disease. First-line medication choices (eg, ibuprofen, naproxen, combined oral contraceptives, or levonorgestrel intrauterine system) reduce symptoms for most people and allow escalating evaluation when pain is severe, progressive, or accompanied by abnormal bleeding, dyspareunia, or infertility. Pain-related absences can often occur.

Pain in primary dysmenorrhea is driven by increased uterine prostaglandin synthesis leading to strong, often cramp-like uterine contractions; NSAIDs for dysmenorrhea inhibit cyclooxygenase (COX‑1/COX‑2) to lower prostaglandins, while hormonal methods such as combined oral contraceptives or a levonorgestrel intrauterine device reduce endometrial proliferation and ovulation-related pain. A guideline-based diagnostic framework uses targeted history, pelvic examination, transvaginal or transabdominal ultrasound and, when indicated, diagnostic laparoscopy to identify secondary causes. ACOG and NICE recommend starting medical management (NSAIDs ± hormonal contraception) before invasive testing unless red flags suggest immediate imaging or specialist referral. NSAIDs are most effective when taken at symptom onset; common regimens include ibuprofen 200–400 mg every 4–6 hours or naproxen 220–500 mg initially then 220 mg every 8–12 hours.

Clinicians should distinguish primary dysmenorrhea from secondary dysmenorrhea because management and prognosis differ: secondary causes such as endometriosis, adenomyosis, uterine fibroids, or pelvic inflammatory disease require targeted imaging or procedural diagnosis and specific therapies. A common misconception is that herbal or topical remedies replace guideline-backed NSAIDs or hormonal contraception; when menstrual pain is progressive, begins after age 25, is associated with dyspareunia, subfertility, or heavy bleeding, referral for transvaginal ultrasound and possible diagnostic laparoscopy is appropriate. For example, persistent pelvic pain during period despite optimal NSAID and contraceptive trials for about three menstrual cycles often indicates endometriosis pain that warrants secondary-care evaluation rather than continued empirical self-treatment. Some imaging modalities such as MRI can help detect adenomyosis in older patients or when ultrasound is inconclusive. Multidisciplinary pain support may help.

Practical steps include initiating an NSAID at symptom onset or prophylactically for each cycle, considering hormonal contraception (combined oral contraceptives or levonorgestrel IUD) for ongoing control, and keeping a simple cycle and symptom diary to document severity, timing, and associated features such as dyspareunia or infertility. If pain remains severe or progressive after three months of optimized medical therapy, or if abnormal bleeding or concerning exam findings occur, referral to gynecology and targeted imaging (transvaginal ultrasound, MRI) should be arranged. Document responses to each therapy. This page contains a structured, step-by-step framework.